360 results on '"Inoue, Masaharu"'
Search Results
2. Gustave Roussy Immune score as a prognostic biomarker in patients with platinum-refractory metastatic urothelial carcinoma treated with pembrolizumab: YUSHIMA study
3. Association between immune-related adverse events and survival in patients with renal cell carcinoma treated with nivolumab plus ipilimumab: immortal time bias-corrected analysis
4. A phase II randomized trial of metastasis-directed therapy with alpha emitter radium-223 in men with oligometastatic castration-resistant prostate cancer (MEDAL)
5. Clinical outcomes of intraductal carcinoma or cribriform in radical prostatectomy specimens of men opting for active surveillance: data from the PRIAS–JAPAN study
6. Outcomes and prognostic factors in patients with synchronous and metachronous oligometastatic urothelial carcinoma with visceral metastases.
7. Deferred radical prostatectomy in patients who initially elected for active surveillance: a multi-institutional, prospective, observational cohort of the PRIAS-JAPAN study
8. Paraganglioma of the urinary bladder initially diagnosed as gastrointestinal stromal tumor requiring combined resection of the rectum: a case report
9. STAT3 Contributes a Favorable Response to Pembrolizumab Through IFN-γ-induced Apoptosis in Urothelial Cancer
10. Incidence and Risk Factors of Hypertension Following Partial Nephrectomy in Patients With Renal Tumors: A Cross-sectional Study of Postoperative Home Blood Pressure and Antihypertensive Medications
11. Treatment‐related neuroendocrine prostate cancer with BRCA2 germline mutation treated with olaparib
12. Preliminary Kidney Parenchymal Ligation Using Endoloop Ligatures—A Simple Method to Achieve a Trifecta in Laparoscopic Partial Nephrectomy Without Hilar Clamping for Polar Complex Tumors
13. Treatment‐related neuroendocrine prostate cancer with BRCA2 germline mutation treated with olaparib.
14. Gasless Single-Port RoboSurgeon Retroperitoneoscopic Adrenalectomy
15. Association between immune-related adverse events and survival in patients with renal cell carcinoma treated with nivolumab plus ipilimumab: Immortal time bias-corrected analysis.
16. Positive regulatory loop of platelet-derived growth factor DD-induced STAT3 activation is associated with poor prognosis in advanced urothelial carcinoma
17. Increasing age predicts adverse pathology including intraductal carcinoma of the prostate and cribriform patterns in deferred radical prostatectomy after upfront active surveillance for Gleason grade group 1 prostate cancer: analysis of prospective observational study cohort
18. A Case of Septic Pulmonary Embolism Caused by Pyelonephritis With Klebsiella pneumoniae in a Patient With Poorly Controlled Type 2 Diabetes Mellitus
19. Pretreatment Hemoglobin Levels and Platelet-to-Lymphocyte Ratio Predict Survival Benefit from Pembrolizumab in Advanced Urothelial Carcinoma
20. Peritoneal closure and the processus vaginalis transection method to prevent inguinal hernia after robot‐assisted radical prostatectomy
21. Paraganglioma with High Levels of Dopamine, Dopa Decarboxylase Suppression, Dopamine β-hydroxylase Upregulation and Intra-tumoral Melanin Accumulation: A Case Report with a Literature Review
22. High Ki-67 Expression Predicts Favorable Survival in Muscle-Invasive Bladder Cancer Patients Treated With Chemoradiation-Based Bladder-Sparing Protocol
23. Additional file 3 of A phase II randomized trial of metastasis-directed therapy with alpha emitter radium-223 in men with oligometastatic castration-resistant prostate cancer (MEDAL)
24. Additional file 2 of A phase II randomized trial of metastasis-directed therapy with alpha emitter radium-223 in men with oligometastatic castration-resistant prostate cancer (MEDAL)
25. Additional file 1 of A phase II randomized trial of metastasis-directed therapy with alpha emitter radium-223 in men with oligometastatic castration-resistant prostate cancer (MEDAL)
26. Clinical outcomes of nivolumab plus ipilimumab in patients with metastatic non‐clear cell renal cell carcinoma: Real‐world data from a Japanese multicenter retrospective study
27. Clinical outcomes of intraductal carcinoma or cribriform in radical prostatectomy specimens of men opting for active surveillance: data from the PRIAS–JAPAN study
28. Late recurrence of late-onset large cell calcifying Sertoli tumor successfully managed by early surgical intervention
29. Clinical outcomes of nivolumab plus ipilimumab in patients with metastatic non‐clear cell renal cell carcinoma: Real‐world data from a Japanese multicenter retrospective study.
30. Dedifferentiated solitary fibrous tumor of the kidney: A case report
31. Impact of adherence to criteria on oncological outcomes of radical prostatectomy in patients opting for active surveillance: data from the PRIAS-JAPAN study
32. Platelet-to-Lymphocyte Ratio Predicts the Efficacy of Pembrolizumab in Patients With Urothelial Carcinoma
33. A case of juvenile-onset pheochromocytoma with KIF1B p.V1529M germline mutation
34. MRI INTENSITY RATIO CURVE ANALYSIS: A NEW OBJECTIVE METHOD FOR CHARACTERIZING SMALL RENAL MASSES: MP78-03
35. ASSOCIATION OF M2 MACROPHAGE INVASION WITH C-REACTIVE PROTEIN IN RENAL CELL CARCINOMA: MP78-05
36. IMPACT OF THE PROSTATE IMAGING REPORTING AND DATA SYSTEM VERSION 2 (PI-RADS V2) ON THE ASSESSMENT OF EXTRACAPSULAR EXTENSION IN PROSTATE CANCER: A MULTIREADER STUDY: PD42-04
37. PREDICTIVE MODEL FOR THERAPEUTIC RESISTANCE USING ERBB2 EXPRESSION STATUS AND KI-67 LABELING INDEX IN MUSCLE-INVASIVE BLADDER CANCER PATIENTS TREATED WITH CHEMORADIOTHERAPY-BASED BLADDER-SPARING PROTOCOL: PD38-05
38. LONGITUDINAL RENAL FUNCTION RECOVERY AFTER RADICAL NEPHRECTOMY AND RISK FACTORS FOR POSTOPERATIVE SEVERE RENAL IMPAIRMENT: A JAPANESE MULTICENTER STUDY: PD29-12
39. IMPACT OF PREBIOPSY MAGNETIC RESONANCE IMAGING (MRI) ON PREOPERATIVE RISK STRATIFICATION FOR BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY: PD30-02
40. PROGNOSTIC IMPACT OF C-REACTIVE PROTEIN KINETICS ON SURVIVAL OF PATIENTS WITH ADVANCED UROTHELIAL CARCINOMA: MP49-05
41. LIKELIHOOD OF UNDERLYING LYNCH SYNDROME IN JAPANESE UPPER TRACT UROTHELIAL CARCINOMA PATIENTS: PD13-06
42. FEASIBILITY OF NON-USE OF ANTIMICROBIAL PROPHYLAXIS IN MINIMALLY INVASIVE CLEAN SURGERY FOR RENAL OR ADRENAL TUMORS: A PROSPECTIVE STUDY OF 668 CASES: MP24-18
43. APPLICABILITY ANALYSIS OF FOCAL THERAPY TO INTERMEDIATE- AND HIGH-RISK PROSTATE CANCER: MP18-07
44. OPTIMAL COMBINATION OF MRI-TARGETED BIOPSY AND SYSTEMATIC BIOPSY FOR MEN WITH SUSPICION OF PROSTATE CANCER: MP16-18
45. HIGH SPECIFICITY OF DIFFUSION-WEIGHTED MRI IN DIFFERENTIATING RESIDUAL BLADDER CANCER FROM POSTOPERATIVE CHANGES: MP13-11
46. THE INCIDENCE OF LATE BLADDER TUMOR RECURRENCE OF UPPER TRACT UROTHELIAL CARCINOMA AND OPTIMAL CYSTOSCOPIC FOLLOW-UP: A MULTICENTER STUDY: MP13-10
47. IMPACT OF ELEVATED URINARY METANEPHRINE/NORMETANEPHRINE AND IMPAIRED GLUCOSE TOLERANCE TEST ON THE DEVELOPMENT OF HYPOGLYCEMIA FOLLOWING REMOVAL OF PHEOCHROMOCYTOMA: MP12-05
48. Real-World Incidence of Immune-Related Adverse Events Associated with Nivolumab Plus Ipilimumab in Patients with Advanced Renal Cell Carcinoma: A Retrospective Observational Study
49. Deferred radical prostatectomy in patients who initially elected for active surveillance: a multi-institutional, prospective, observational cohort of the PRIAS-JAPAN study
50. Progression of hypertension after partial nephrectomy in patients with renal tumors: A preliminary report
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.